ARCTURUS THERAPEUTICS HOLDIN (ARCT) Stock Cash Flow
NASDAQ:ARCT - Nasdaq - US03969T1097 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.64M | -29.73M | 9.35M | -203.67M | -72.15M | |||
| Depreciation Amortization | 3.54M | 2.96M | 1.53M | 1.19M | 880.00K | |||
| Change In Working Capital | -39.45M | 7.38M | -12.56M | 31.23M | 21.22M | |||
| Interest Paid | 27.00K | 2.13M | 810.00K | 680.00K | 750.00K | |||
| Other non cash items | 38.47M | 1.29M | 33.67M | 36.21M | 7.19M | |||
| OPERATING CASH FLOW | -60.09M | -18.10M | 31.99M | -135.04M | -42.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.52M | -2.90M | -7.73M | -3.41M | -1.74M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -1.52M | -2.90M | -7.73M | -3.41M | -1.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -27.36M | -5.00M | 46.60M | 0.00 | |||
| Stock Issued/Repurchased | 6.63M | 3.28M | 2.14M | 1.42M | 436.15M | |||
| FINANCING CASH FLOW | -13.37M | -24.09M | -2.86M | 48.02M | 436.15M | |||
| CHANGE IN CASH | -74.98M | -45.09M | 21.40M | -90.43M | 391.55M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -60.09M | -18.10M | 31.99M | -135.04M | -42.86M | |||
| Capital Expenditure | -1.52M | -2.90M | -7.73M | -3.41M | -1.74M | |||
| FREE CASH FLOW | -61.61M | -21.00M | 24.26M | -138.45M | -44.60M | |||
All data in USD